Last reviewed · How we verify
NCT05869318: RESEC
Respiratory Effects of E-Cigarettes in Obese Youth
NA trial testing ECIG own in E-Cig Use in 56 participants. Participants enrolled and being followed up; not accepting new ones.
21 May 2024
Quick facts
| Lead sponsor | Ohio State University Comprehensive Cancer Center |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 56 |
| Start date | 4 April 2023 |
| Primary completion | 21 May 2024 |
| Estimated completion | 31 December 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- ECIG own
- ECIG Vuse
Conditions studied
- E-Cig Use — all drugs for E-Cig Use →
Sponsor
Ohio State University Comprehensive Cancer Center
Who can join
Adults 21 to 25, any sex, with E-Cig Use. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To determine vaping behaviors and respiratory function in obese and nonobese youth e-cigarette users.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05869318
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for E-Cig Use
Currently open trials in the same condition.
- NCT07039292 — Clinical Alternatives for Reducing Harm Using E-cigarettes · NA · recruiting
- NCT07167225 — Carcinogen and Toxicant Exposure Among Young Adults Who Co-Use E-cigarettes and Cannabis (Co-Tox Study) · recruiting
- NCT06862050 — BREATHE Free: a Pilot Feasibility Trial · NA · recruiting
- NCT06860698 — The Impact of Chronic E-Cigarette Usage on Microvascular Health · recruiting
Other Ohio State University Comprehensive Cancer Center trials
Trials by the same sponsor.
- NCT06816979 — Lumbar Punctures for the Detection of ctDNA in the Cerebrospinal Fluid of Patients With Stage III and IV Non-Small Cell · NA · not yet recruiting
- NCT07529483 — Endoscopic Ultrasound-Guided Chemoablation for the Treatment of Pancreatic Cysts · Phase 2 · not yet recruiting
- NCT07455513 — A Novel Tobacco Cessation Resource for Smokers With a Diagnosed or Suspected Thoracic Cancer · NA · not yet recruiting
- NCT07217990 — Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer · Phase 1, PHASE2 · not yet recruiting
- NCT07503925 — THRIVE Study: Understanding How Oral Nicotine Pouches Affect Public Health · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05869318 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ohio State University Comprehensive Cancer Center
- Last refreshed: 20 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05869318.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing